(3 références)Aperçu rapide pour Annexin V Apoptosis Kit-FITC (ABIN376221)
Antigène
Voir toutes Annexin V (ANXA5) KitsApplication
-
-
Conjugué
- FITC
-
Attributs du produit
- ApoScreen® Annexin V Apoptosis Kit-FITC
-
-
Annexin A5 (ANXA5) ELISA Kit
ANXA5 Reactivité: Humain Colorimetric Sandwich ELISA 31.2 pg/mL - 2000 pg/mL Plasma, Serum, Tissue Homogenate
Annexin A5 (ANXA5) ELISA KitANXA5 Reactivité: Rat Colorimetric Sandwich ELISA 0.313 ng/mL - 20 ng/mL Plasma, Serum, Tissue Homogenate
Annexin A5 (ANXA5) ELISA KitANXA5 Reactivité: Souris Colorimetric Sandwich ELISA 1.563 ng/mL - 100 ng/mL Plasma, Serum, Tissue Homogenate
Annexin A5 (ANXA5) ELISA KitANXA5 Reactivité: Humain Colorimetric Sandwich ELISA 0.31 ng/mL - 20 ng/mL Cell Culture Supernatant, Plasma, Serum
Annexin A5 (ANXA5) ELISA KitANXA5 Reactivité: Singe Colorimetric Sandwich ELISA 1.563 ng/mL - 100 ng/mL Plasma, Serum, Tissue Homogenate
Annexin A5 (ANXA5) ELISA KitANXA5 Reactivité: Poulet Colorimetric Sandwich ELISA 1.563 ng/mL - 100 ng/mL Plasma, Serum, Tissue Homogenate
Annexin A5 (ANXA5) ELISA KitANXA5 Reactivité: Cheval Colorimetric Sandwich ELISA 1.563 ng/mL - 100 ng/mL Plasma, Serum, Tissue Homogenate
Annexin A5 (ANXA5) ELISA KitANXA5 Reactivité: Souris Colorimetric Sandwich ELISA 15.6 pg/mL - 1000 pg/mL Plasma, Serum
Annexin A5 (ANXA5) ELISA KitANXA5 Reactivité: Rat Colorimetric Sandwich ELISA 0.15 ng/mL - 10 ng/mL Plasma, Serum
-
-
Restrictions
- For Research Use only
-
-
-
Conseil sur la manipulation
-
Protect conjugated products from light.
Each reagent is stable for the period shown on the bottle label if stored as directed. -
Stock
- 4 °C
-
-
-
: "Homozygous mdm2 SNP309 cancer cells with compromised transcriptional elongation at p53 target genes are sensitive to induction of p53-independent cell death." dans: Oncotarget, Vol. 6, Issue 33, pp. 34573-91, (2016) (PubMed).
: "8-Amino-adenosine activates p53-independent cell death of metastatic breast cancers." dans: Molecular cancer therapeutics, Vol. 11, Issue 11, pp. 2495-504, (2012) (PubMed).
: "Inhibition effect of siRNA-downregulated UHRF1 on breast cancer growth." dans: Cancer biotherapy & radiopharmaceuticals, Vol. 26, Issue 2, pp. 183-9, (2011) (PubMed).
-
: "Homozygous mdm2 SNP309 cancer cells with compromised transcriptional elongation at p53 target genes are sensitive to induction of p53-independent cell death." dans: Oncotarget, Vol. 6, Issue 33, pp. 34573-91, (2016) (PubMed).
-
- Annexin V (ANXA5) (Annexin A5 (ANXA5))
-
Autre désignation
- Annexin V
Antigène
-
